What is the current stock price of Sysmex Corporation (SSMXY)?

As of the latest market data, Sysmex Corporation (SSMXY) is trading at $9.11. The stock has seen a gain of 2.13% today.

Does Sysmex Corporation (SSMXY) pay a dividend?

Based on current data, Sysmex Corporation does not have a confirmed active dividend policy.

What is the market cap of Sysmex Corporation?

The current market capitalization of Sysmex Corporation (SSMXY) is approximately unavailable.

SSMXY

Sysmex Corporation·Healthcare

9.11

2.130%(+0.19)

Market Closed

Last Updated: — ET

52W L: $8.1552W H: $19.59

SSMXY NEWS

defenseworld.net

3d ago

Thermo Fisher Scientific (NYSE:TMO) versus Sysmex (OTCMKTS:SSMXY) Head to Head Contrast

Thermo Fisher Scientific (NYSE: TMO - Get Free Report) and Sysmex (OTCMKTS:SSMXY - Get Free Report) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, valuation, risk, dividends, institutional ownership, profitability and analyst recommendations. Dividends Thermo Fisher Scientific pays an annual dividend

defenseworld.net

Mar 28

Sysmex (OTCMKTS:SSMXY) vs. DexCom (NASDAQ:DXCM) Head to Head Survey

Sysmex (OTCMKTS:SSMXY - Get Free Report) and DexCom (NASDAQ: DXCM - Get Free Report) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, profitability, dividends, risk, valuation, analyst recommendations and institutional ownership. Profitability This table compares Sysmex and DexCom's net margins, return

defenseworld.net

Feb 28

Sysmex Corporation ADR (OTCMKTS:SSMXY) Short Interest Down 42.7% in February

Sysmex Corporation ADR (OTCMKTS:SSMXY - Get Free Report) was the recipient of a significant decrease in short interest in February. As of February 13th, there was short interest totaling 65,013 shares, a decrease of 42.7% from the January 29th total of 113,501 shares. Currently, 0.0% of the shares of the company are short sold. Based

defenseworld.net

Jan 29

Short Interest in Sysmex Corporation ADR (OTCMKTS:SSMXY) Decreases By 53.9%

Sysmex Corporation ADR (OTCMKTS:SSMXY - Get Free Report) was the recipient of a significant decrease in short interest in January. As of January 15th, there was short interest totaling 127,705 shares, a decrease of 53.9% from the December 31st total of 277,294 shares. Based on an average trading volume of 698,584 shares, the days-to-cover ratio

Company Profile

Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan. The company offers three-part and five-part white blood cell differentiation instruments for use in hematology; and transport systems for high-volume testing in labs. It also provides urine formed sediment analysis systems; automated immunochemistry systems, which perform assays on minute sample quantities, as well as reagents to test for infectious disease and tumor markers; and flow cytometers to perform analysis in diagnosing leukemia, malignant lymphoma, and HIV/AIDS. In addition, the company offers cancer lymph node metastasis testing systems to detect information to help in diagnosing lymph node metastasis; cancer genome profiling systems; and cytogenic testing and lab assay services. It is also involved in the development and sale of software for diagnostic information systems; provision of facility management, office, and welfare services; development, manufacture, and sale of nucleic acid analogs; development, operation, and maintenance of IT solutions, platforms, and applications related to digital medicine; marketing, development, design, manufacture, sale, and after-sales service related to medical robots; and distribution and after sales support of medical devices and reagents for biotechnology, medical technology, and molecular cell analysis. The company serves national and other public hospitals, private hospitals, universities, research institutes, other medical institutions, etc. It also exports its products to approximately 190 countries. Sysmex Corporation has a strategic alliance with QIAGEN N.V. for the development and commercialization of cancer companion diagnostics using Plasma-Safe-SeqS technology. The company was formerly known as TOA Medical Electronics Co., Ltd. and changed its name to Sysmex Corporation in October 1998. Sysmex Corporation was founded in 1968 and is headquartered in Kobe, Japan.

Sector

Healthcare

Industry

Medical - Instruments & Supplies

Employees

10,042

IPO Date

2011-10-17

Beta

0.65

Websitewww.sysmex.co.jp↗